medical dermatology drug innovation  home  dermira contact us news menu menu skin science reenvisioned with experienced insight and visionary science dermira is looking deeper to help transform medical dermatology see more skin science reexamined focused on the need for important new treatments for chronic skin conditions dermira is looking deeper to bring biotech ingenuity to medical dermatology see more skin science reimagined looking deeper to understand and meet the needs of patients and their physicians dermira is identifying and developing leadingedge medical dermatology programs see more our focus hyperhidrosis millions suffer from excessive sweating beyond what is physiologically required but few effective treatment options are available psoriasis new therapies are needed to help address unmet patient needs as patient responses to the most commonly prescribed treatments vary widely acne no clinically meaningful innovation has occurred in over a decade for this skin condition that affects millions careers we are enthusiastic about the work we do and our culture if you are an energetic selfstarter who wants to join a great team and make a difference in the lives of patients we may have a role for you join our team pipeline with our deep insight in skin biology and our thorough understanding of patient needs we are developing a portfolio of unique patientcentric therapies view our pipeline recent news  ucb and dermira announce us and eu regulatory submissions for cimzia® certolizumab pegol for the treatment of moderatetosevere chronic plaque psoriasis  newly published nonclinical data highlight the role of olumacostat glasaretil in sebum inhibition  dermira announces appointment of ian clements as vice president investor relations  dermira to present at jefferies  global healthcare conference  dermira announces closing of  convertible senior notes offering view all news medical dermatology drug innovation  home  dermira contact us news menu menu skin science reenvisioned with experienced insight and visionary science dermira is looking deeper to help transform medical dermatology see more skin science reexamined focused on the need for important new treatments for chronic skin conditions dermira is looking deeper to bring biotech ingenuity to medical dermatology see more skin science reimagined looking deeper to understand and meet the needs of patients and their physicians dermira is identifying and developing leadingedge medical dermatology programs see more our focus hyperhidrosis millions suffer from excessive sweating beyond what is physiologically required but few effective treatment options are available psoriasis new therapies are needed to help address unmet patient needs as patient responses to the most commonly prescribed treatments vary widely acne no clinically meaningful innovation has occurred in over a decade for this skin condition that affects millions careers we are enthusiastic about the work we do and our culture if you are an energetic selfstarter who wants to join a great team and make a difference in the lives of patients we may have a role for you join our team pipeline with our deep insight in skin biology and our thorough understanding of patient needs we are developing a portfolio of unique patientcentric therapies view our pipeline recent news  ucb and dermira announce us and eu regulatory submissions for cimzia® certolizumab pegol for the treatment of moderatetosevere chronic plaque psoriasis  newly published nonclinical data highlight the role of olumacostat glasaretil in sebum inhibition  dermira announces appointment of ian clements as vice president investor relations  dermira to present at jefferies  global healthcare conference  dermira announces closing of  convertible senior notes offering view all news market report dermira inc  product pipeline review   about us • publishers • contact us • cart login  register all industries business  finance  business  financial services  insurance  marketing consumer  food  beverages  consumer goods  food  retailing healthcare  biotechnology  healthcare  medical devices  pharmaceuticals heavy industry  construction  energy  manufacturing  materials  transportation internet  media  ebusiness  internet  media  publishing public sector  defense  education  government telecom  computing  computer technology  fixed networks  software  wireless companycountry reports  company reports  country reports  regional reports   processing dermira inc  product pipeline review   nov    global markets direct   pages  usd  click here to open the popup youve added the following report to your cartclose cart summary total items subtotal      report summary table of contents companies request details related global markets directs dermira inc  product pipeline review   provides an overview of the dermira incs pharmaceutical research and development focusthis report provides comprehensive information on the current therapeutic developmental pipeline of dermira incs complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projectsglobal markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets directs team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basisthe report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass productsnote certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated diseasescopethe report provides brief overview of dermira inc including business description key information and facts and its locations and subsidiariesthe report reviews current pipeline of dermira incs human therapeutic division and enlists all their major and minor projectsthe report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestonesspecial feature on outlicensed and partnered product portfoliothe report summarizes all the dormant and discontinued pipeline projectslatest company statementlatest news and deals relating to the dermira incs pipeline productsreasons to buyevaluate dermira incs strategic position with total access to detailed information on its product pipelineassess the growth potential of dermira inc in its therapy areas of focusidentify new drug targets and therapeutic classes in the dermira incs rd portfolio and develop key strategic initiatives to reinforce pipeline in those areasexploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gapsdevelop strategic initiatives by understanding the focus areas of dermira inc and exploit collaboration and partnership opportunitiesidentify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantageplan mergers and acquisitions effectively by identifying the most promising pipeline of dermira incdevelop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scopeexplore the dormant and discontinued projects of dermira inc and identify potential opportunities in those areasavoid intellectual property rights related issues table of contentstable of contentslist of tableslist of figuresdermira inc snapshotdermira inc overviewkey informationkey factsdermira inc  research and development overviewkey therapeutic areasdermira inc  pipeline reviewpipeline products by stage of developmentpipeline products  monotherapypipeline products  partnered productspartnered productscombination treatment modalitiesdermira inc  pipeline products glancedermira inc  late stage pipeline productsphase iii productscombination treatment modalitiesdermira inc  clinical stage pipeline productsphase ii productscombination treatment modalitiesdermira inc  drug profilescertolizumab pegolproduct descriptionmechanism of actionrd progressdrmproduct descriptionmechanism of actionrd progressdrmproduct descriptionmechanism of actionrd progressdrmproduct descriptionmechanism of actionrd progressdermira inc  pipeline analysisdermira inc  pipeline products by targetdermira inc  pipeline products by route of administrationdermira inc  pipeline products by molecule typedermira inc  pipeline products by mechanism of actiondermira inc  recent pipeline updatesdermira inc  dormant projectsdermira inc  locations and subsidiarieshead officeappendixmethodologycoveragesecondary researchprimary researchexpert panel validationcontact usdisclaimerlist of tablesdermira inc key informationdermira inc key factsdermira inc  pipeline by indication dermira inc  pipeline by stage of development dermira inc  monotherapy products in pipeline dermira inc  partnered products in pipeline dermira inc  partnered products combination treatment modalities dermira inc  phase iii dermira inc  phase ii dermira inc  pipeline by target dermira inc  pipeline by route of administration dermira inc  pipeline by molecule type dermira inc  pipeline products by mechanism of action dermira inc  recent pipeline updates dermira inc  dormant developmental projectslist of figuresdermira inc  pipeline by top  indication dermira inc  pipeline by stage of development dermira inc  monotherapy products in pipeline dermira inc  partnered products in pipeline dermira inc  pipeline by top  target dermira inc  pipeline by top  route of administration dermira inc  pipeline by top  molecule type dermira inc  pipeline products by top  mechanism of action  companies mentioned in this reportdermira inc this report does not have a press release associated with it order today format pdf  usd license single user delivery by email   business day the fast market research advantage only the best all of our research is sourced from the most trusted and established global analysts and consultancies client focused from startups to multinationals we focus on providing the right research to our diverse client base shop securely our usbased customer service team and ecommerce systems adhere to the highest data security standards industryleading customer support individualized assistance from our expert staff is never more than an email or phone call away best price guarantee we are committed to providing the best research at the lowest cost we will match any published price for the same report guaranteed easy ordering once you’ve found the right report click ‘order now’ and complete the checkout process using any major credit card check or wirebank transferneed multiuser or enterprise license pricing contact us for a custom quote about the publisher global markets direct is a leading provider of global business intelligence and market analysis it publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industryspecific information publisher details privacy policy  terms of use  flashalerts copyright copy  fast market research inc stocks index  markets index bulletin investor alert new york markets open in market snapshot analyst ratings stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  am edt july   marketstatecountryus new york pre marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest aellie maes stock set for record selloff after results disappoints outlook slashed astock market set to extend fresh tech rout as amazon disappoints gdp data ahead aatlantic media selling ownership stake to organization run by laurene powell jobs aus gdp speeds up to  in nd quarter aretail investors wait this long to dive into ipos amerck expects june cyberattack to affect companys  financial performance achevron swings to profit as charges shrink achevrons stock slips  premarket after q results amcconnell blames democrats after healthcare loss  house approves borderwall money achevron q revenue  bln vs  bln a year ago factset consensus  bln achevron q factset eps consensus  cents achevron q eps includes charges of  mln and gains from asset sales of  mln ayear treasury yield down by  basis point to  asp  futures down  at  abreakingus stock futures trim losses after gdp data anasdaq futures down  at  adow futures off  at  ayear treasury yield down by  basis point to  achevron q eps  cents vs pershare loss  cents ayear treasury yield down by  basis points to  loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  bing places for business bing places for business sign in using your microsoft account work account google account facebook account dont have an account create one stocks index  markets index bulletin investor alert new york markets open in market snapshot analyst ratings stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  am edt july   marketstatecountryus new york pre marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest aellie maes stock set for record selloff after results disappoints outlook slashed astock market set to extend fresh tech rout as amazon disappoints gdp data ahead aatlantic media selling ownership stake to organization run by laurene powell jobs aus gdp speeds up to  in nd quarter aretail investors wait this long to dive into ipos amerck expects june cyberattack to affect companys  financial performance achevron swings to profit as charges shrink achevrons stock slips  premarket after q results amcconnell blames democrats after healthcare loss  house approves borderwall money achevron q revenue  bln vs  bln a year ago factset consensus  bln achevron q factset eps consensus  cents achevron q eps includes charges of  mln and gains from asset sales of  mln ayear treasury yield down by  basis point to  asp  futures down  at  abreakingus stock futures trim losses after gdp data anasdaq futures down  at  adow futures off  at  ayear treasury yield down by  basis point to  achevron q eps  cents vs pershare loss  cents ayear treasury yield down by  basis points to  loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  dermira inc  middlefield rd menlo park ca pharmaceutical productswholesale  mapquest dermira inc  middlefield rd menlo park ca  reviews   website menu  reservations make reservations order online tickets tickets see availability nearby directions  date name shares transaction value  eugene andrew bauer chief medical officer director    disposition at  per share   thomas g wiggans ceo  chairman of the board director    disposition at  per share   thomas g wiggans ceo  chairman of the board director    derivativenonderivative trans at  per share   eugene andrew bauer chief medical officer director    disposition at  per share   thomas g wiggans ceo  chairman of the board director    disposition at  per share   thomas g wiggans ceo  chairman of the board director    derivativenonderivative trans at  per share   thomas g wiggans ceo  chairman of the board director    disposition at  per share   thomas g wiggans ceo  chairman of the board director    derivativenonderivative trans at  per share   christopher m griffith svp head corp dev  strategy    disposition at  per share   christopher m griffith svp head corp dev  strategy    derivativenonderivative trans at  per share   christopher m griffith svp head corp dev  strategy    derivativenonderivative trans at  per share   thomas g wiggans ceo  chairman of the board director    gift at  per share   thomas g wiggans ceo  chairman of the board director    gift at  per share   thomas g wiggans ceo  chairman of the board director    disposition at  per share   thomas g wiggans ceo  chairman of the board director    disposition at  per share   eugene andrew bauer chief medical officer director    disposition at  per share   bill r ringo director    disposition at  per share   thomas g wiggans ceo  chairman of the board director    derivativenonderivative trans at  per share   bill r ringo director    derivativenonderivative trans at  per share   christopher m griffith svp head corp dev  strategy    disposition at  per share   christopher m griffith svp head corp dev  strategy    derivativenonderivative trans at  per share   christopher m griffith svp head corp dev  strategy    derivativenonderivative trans at  per share   thomas g wiggans ceo  chairman of the board director    disposition at  per share   thomas g wiggans ceo  chairman of the board director    disposition at  per share   eugene andrew bauer chief medical officer director    disposition at  per share   eugene andrew bauer chief medical officer director    disposition at  per share   bill r ringo director    disposition at  per share   thomas g wiggans ceo  chairman of the board director    derivativenonderivative trans at  per share   bill r ringo director    derivativenonderivative trans at  per share  newslatestcompanyusderm marketwatch news on derm no news currently available for derm newsnonmarketwatchcompanyusderm other news on derm  assets with negative performances  pm july    gurufocuscom novo a buys anaptysbio inc obseva sa dermira inc sells vanguard total stock market colucid   pm june    gurufocuscom premarket analyst action  healthcare  am june    seeking alpha baker bros advisors lp buys incyte corp avexis inc la jolla pharmaceutical co sells abbvie   pm june    gurufocuscom novo a buys anaptysbio inc obseva sa dermira inc sells vanguard total stock market colucid   pm june    gurufocuscom novo a buys anaptysbio inc obseva sa dermira inc sells vanguard total stock market colucid   pm june    gurufocuscom novo a buys anaptysbio inc obseva sa dermira inc sells vanguard total stock market colucid   pm june    gurufocuscom dermira derm presents at jefferies  global healthcare conference  slideshow  pm june    seeking alpha teva pharma eagle pharma depomed among slew getting price haircuts  pm may    investors business daily eam investors llc buys newlink genetics corp teladoc inc esperion therapeutics inc sells   pm may    gurufocuscom heres why dermira fell as much as  this morning  pm may    motley fool demira derm presents at th annual needham healthcare conference  slideshow  pm april    seeking alpha premarket analyst action  healthcare  am march    seeking alpha dermiras derm ceo tom wiggans on q  results  earnings call transcript  pm feb    seeking alpha dermiras latestage assets are undervalued  am feb    seeking alpha dermira how biosimilars threaten sales of cimzia  am jan    seeking alpha biotech forum daily digest keytruda continues to power merck revisiting invitae  am jan    seeking alpha  pharmaceuticals stocks to sell now  am dec    investorplacecom biopharmx pivot means its time to wait  am nov    seeking alpha q dermira inc  pm nov    edgar online  edg  q k loading more headlines at a glance dermira inc  middlefield road suite  menlo park california  phone   industry biotechnology sector health carelife sciences fiscal yearend  view sec filings revenue m net income m  sales growth  employees  annual report for derm newspressreleasecompanyusderm press releases on derm ucb and dermira announce us and eu regulatory submissions for cimziar certolizumab pegol for the treatment of moderatetosevere chronic plaque psoriasis  am july    globenewswire daily technical summary reports on biotech stocks  concordia cytokinetics dermira and endocyte  am june    pr newswire  prf newly published nonclinical data highlight the role of olumacostat glasaretil in sebum inhibition  am june    globenewswire dermira announces appointment of ian clements as vice president investor relations  am june    globenewswire dermira to present at jefferies  global healthcare conference  pm may    globenewswire dermira announces closing of  convertible senior notes offering  pm may    globenewswire dermira prices offering of  million of  convertible senior notes  pm may    globenewswire dermira announces proposed offering of  million of convertible senior notes  pm may    globenewswire dermira reports first quarter  financial results and provides corporate update  pm may    globenewswire dermira to present at needham th annual healthcare conference  pm march    globenewswire dermira presents new data highlighting patient outcomes in axillary hyperhidrosis at maui derm meeting  am march    globenewswire dermira to highlight data for three clinical programs at annual maui derm meeting  am march    globenewswire dermira announces closing of public offering of common stock and full exercise of underwriters option to purchase additional shares  pm march    globenewswire new cimziar certolizumab pegol data in moderatetosevere plaque psoriasis and psoriatic arthritis presented at american academy of dermatology  annual meeting  am march    globenewswire dermira presents new data in primary axillary hyperhidrosis and acne at american academy of dermatology  annual meeting  am march    globenewswire dermira to present at cowen and company th annual health care conference  pm march    globenewswire dermira prices  million public offering of common stock  pm march    globenewswire dermira announces proposed public offering of common stock  pm feb    globenewswire dermira reports fourth quarter and full year  financial results and provides corporate update  pm feb    globenewswire dermira data from drm and olumacostat glasaretil clinical programs to be presented at american academy of dermatology annual meeting  pm feb    globenewswire loading more headlines trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  am edt july   marketstatecountryus new york pre marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest aellie maes stock set for record selloff after results disappoints outlook slashed astock market set to extend fresh tech rout as amazon disappoints gdp data ahead aatlantic media selling ownership stake to organization run by laurene powell jobs aus gdp speeds up to  in nd quarter aretail investors wait this long to dive into ipos amerck expects june cyberattack to affect companys  financial performance achevron swings to profit as charges shrink achevrons stock slips  premarket after q results amcconnell blames democrats after healthcare loss  house approves borderwall money achevron q revenue  bln vs  bln a year ago factset consensus  bln achevron q factset eps consensus  cents achevron q eps includes charges of  mln and gains from asset sales of  mln ayear treasury yield down by  basis point to  asp  futures down  at  abreakingus stock futures trim losses after gdp data anasdaq futures down  at  adow futures off  at  ayear treasury yield down by  basis point to  achevron q eps  cents vs pershare loss  cents ayear treasury yield down by  basis points to  loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  derm  stock quote for dermira inc  msn money msn back to msn home money web search sign in change language  content américa latina español argentina español australia english belgië nederlands belgique français brasil português canada english canada français chile español colombia español danmark dansk deutschland deutsch españa español france français india english indonesia bahasa indonesia ireland english italia italiano malaysia english méxico español nederland nederlands new zealand english norge norsk bokmål österreich deutsch perú español philippines english polska polski portugal português schweiz deutsch singapore english south africa english suisse français suomi suomi sverige svenska türkiye türkçe united arab emirates english united kingdom english united states english united states español venezuela español việt nam tiếng việt ελλάδα ελληνικά россия pусский ישראל עברית‏ الإمارات العربية المتحدة العربية‏ المملكة العربية السعودية العربية‏ مصر العربية‏ ไทย ไทย 한국 한국어      語   switch to latino español feedback help adchoices dermira inc nasdaq derm us markets open in min adchoices  ▼   premarket     july    pm edt delayed  minutes nasdaq currency in usd save summary financials analysis options ownership company history related open  previous close  volume avg k k days range  wk range  market cap b dividend rate  yield  beta  shares outstanding m pe ratio eps  recent news ucb and dermira announce us and eu regulatory benzinga  days ago briefucb and dermira announce us and eu regulatory submissions for cimzia reuters  days ago update evercore isi starts dermira derm at outperform street underestimating acne phase  success streetinsider  tekla capital management cut horizon pharma plc hznp stake  bullish analysts covering truecar true the bibey post  hrs ago stocks earning overview boston scientific corporation bsx healthcaremenunet  hrs ago canaan partners closes latest venture capital fund at m finsmescom  hrs ago ucb  with a strong first half year  – giving rise …  traders  day ago simon property group inc overnewsmagazinecom  day ago ny has  million position in simon property group inc nysespg techzolixcom  day ago amf pensionsforsakring ab maintains stake in simon property group inc spg hoyentvcom  day ago international business machines nyseibm experiences lighter than average trading volume football hebdo  days ago international business machines corporation lazer esportes  days ago oppenheimer reaffirms the hold rating theyve had for ibm nyseibm shares le camp des recrues  days ago international business machines corporation plans quarterly dividend of  ibm hoyentvcom  days ago international business machines corporation nyseibm downgraded to strong sell at bidaskclub bulhufas  days ago dermira inc nasdaqderm sees unusual trading volume in its shares highlight press  days ago ucb  and dermira announce us and eu regulatory submissions …  traders  days ago anadarko petroleum corporation nyseapc coverage initiated by analysts at citigroup inc badhubnet  days ago adchoices adchoices adchoices markets dow dow ▲    last updated time   am edt markets nasdaq nasdaq ▼    ftse  ftse  ▼    nyse composite nyse composite ▼    adchoices feedback send feedback provide feedback report a problem we appreciate your input select a category im having problems with top destinations im having issues searching im having problems with featured apps i see an error in the content other how we can improve please give an overall site rating submit close privacy statement help help  support dermira inc nasdaqderm dermira inc derm product news news  stocknewscom     follow us stocktwits twitter dermira inc derm product news news derm – dermira and ucb submit sbla for cimzia to fda and ema jul    am  by stocknewscom staff product news key facts surrounding this news item derm had a powr rating of c neutral coming into today derm was  above its day moving average coming into today derm was  above its day moving average coming into today derm was  above its day moving average coming into today derm was  below its day moving average coming into today derm was  below its day moving average coming into today derm had returned  yeartodate leading up to today’s news versus a  return from the benchmark sp  during the same period more info about dermira inc derm dermira is a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and their patients the company was founded in  and is based in menlo park california view our full derm ticker page with ratings news and more derm at a glance derm current powr rating™ overall powr rating™ derm current price   more derm ratings data and news derm price reaction the day of this event jul  derm closing price derm volume from avgleading up to this eventderm mo returnnaafter this eventderm day return derm price chart more dermira inc derm news view all eventdate symbol news detail start price end price change powr rating loading please wait view all derm news page generated in  seconds